These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 982623)

  • 1. [Determination of fibrin and fibrinogen split products by their anticoagulant activity].
    Belitser VA; Varetskaia TV; Tsynkalovskaia SN; Tsariuk LA; Shevchenko LI
    Ukr Biokhim Zh; 1976; 48(4):521-32. PubMed ID: 982623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of fibrinuria with fibrinogen split-product E following kidney allotransplantation.
    Zühlke V; Hölscher M; Reichel W; Pernice G
    Contrib Nephrol; 1975; 1():103-8. PubMed ID: 797519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine fibrin degradation products in detection and management of acute and chronic renal transplant rejection.
    Cattran DC; Hockley M; Fenton SS; Wilson DR
    Clin Nephrol; 1977 Jun; 7(6):255-61. PubMed ID: 326454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
    Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M
    Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of fibrin (fibrinogen) degradation products in urine].
    Andreenko GV; Podorol'skaia LV
    Lab Delo; 1983; (4):35-8. PubMed ID: 6191081
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical significance of urinary fibrin-fibrinogen degradation products in renal disease].
    Umitsu Y
    Nihon Jinzo Gakkai Shi; 1976 Jun; 18(6):371-87. PubMed ID: 988340
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fibrin degradation products in the urine in renal diseases].
    Iversen BM; Ofstad J; Thunold S; Willassen Y
    Tidsskr Nor Laegeforen; 1976 Jan; 96(2):91-3. PubMed ID: 766292
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of the quantitative determination of "fibrin degradation products" in renal diseases.
    Chin Med J (Engl); 1980 Jul; 93(7):483-6. PubMed ID: 6772396
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinogen-fibrin degradation products in renal disorders.
    Dube B; Srivastava PK; Padmanabhan R; Dube RK
    Indian J Pathol Microbiol; 1979 Oct; 22(4):313-22. PubMed ID: 548482
    [No Abstract]   [Full Text] [Related]  

  • 12. A simple test for early detection of severe renal homograft rejection.
    Oppolzer R; Leithner C; Wolf A; Pinggera W; Stummvoll H
    Proc Eur Dial Transplant Assoc; 1975; 11():326-32. PubMed ID: 667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrin degradation products in the urine in diabetic nephropathy].
    Khristov V; Apostolov P; Stamenova T
    Vutr Boles; 1979; 18(4):32-6. PubMed ID: 494630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products].
    Dyr JE; Cajthamlová H; Suttnar J
    Cas Lek Cesk; 1990 Oct; 129(43):1349-51. PubMed ID: 2249231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of two new assays for determination of serum fibrinogen/fibrin degradation products.
    Sumner K; Feller E; Galanakis DK; Mosesson MW
    Ann Clin Lab Sci; 1979; 9(5):362-7. PubMed ID: 533231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic value of determining urinary fibrin split products in glomerulonephritis, pyelonephritis and graft rejection].
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Z Urol Nephrol; 1978 Nov; 71(11):787-97. PubMed ID: 366978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggristin (ristomycin) precipitation test: a new tool for the detection of fibrin monomer and fibrin degradation products.
    Pfliegler G; Vogel G; Boda Z; Zajka G; Rak K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(4):629-35. PubMed ID: 2414192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic significance of the demonstration of fibrin and fibrinogen degradation products in the urine].
    Bendel M; Oetliker O; Montandon A; Beck EA
    Schweiz Med Wochenschr; 1975 Aug; 105(33):1040-7. PubMed ID: 1099647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Letter: Fibrin metabolites in the urine in kidney diseases].
    Arnesen M; Godal HC
    Tidsskr Nor Laegeforen; 1976 Feb; 96(6):396. PubMed ID: 1257987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.